Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maximal Usage PK and Safety of Zoryve in Pediatric Psoriasis
NCT04655313Phase 2Completed
- Sponsor
- Arcutis Biotherapeutics
- Start
- Nov 2020
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of roflumilast in plaque psoriasis, sponsored by Arcutis Biotherapeutics. Started Nov 2020; status: completed.
02
Drugs
roflumilast
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT04655313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04655313.